Physical activity in established rheumatoid arthritis and variables associated with maintenance of physical activity over a seven-year period – a longitudinal observational study

Table 4 Variables (from 2010) associated with an improvement in physical activity level between 2010 and 2017 (n = 211) vs. not meeting MVPA recommendations at any occasion (n = 116). A logistic regression model adjusted for age, gender, and smoking habits

2010		n^a	OR	95% CI	p-value
Age		322	0.963	0.945–0.981	< 0.001
Gender	men	97	1
	women	225	1.061	0.628–1.972	0.826
Smoking habits	Non smoker	125	1
	Smoker	59	0.732	0.379–1.416	0.355
	Previous smoker	138	0.683	0.403–1.156	0.155
Disease duration, years		322	0.991	0.931–1.054	0.764
BMI	18.5–24.9, %	105	1
	< 18.5, %	3	1.964	0.166–23.159	0.592
	25.0–29.9, %	130	0.829	0.427–1.458	0,516
	≥30, %	62	0.555	0.276–1.116	0.099
Cardiovasc	no	171	1
	yes	144	0.623	0.371–1.048	0.074
Pulmonary	no	283	1
	yes	34	1.111	0.523–2.357	0.785
TJC		318	0.946	0.906–0.987	0.011
SJC		314	0.956	0.908–1.006	0.082
PatGA (0–10)		311	0.904	0.812–1.006	0.065
Pain (0–10)		315	0.915	0.826–1.015	0.094
Fatigue (0–10)		317	0.929	0.852–1.012	0.092
HAQ (0–3)		322	0.719	0.463–1.116	0.141
EQ 5D (0–1)		310	3.773	1.059–13.441	0.041
Tender regions (0–18)		322	0.926	0.867–0.988	0.020
DMARD	No DMARD	50	1
	cDMARD^b	166	1.180	0.583–2.387	0.645
	Biologic^b	85	1.401	0.650–3.021	0.390
	Only CS	13	1.263	0.326–4.897	0.735

^a included in the multivariate analyses, ^bwith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids

ISSN: 2520-1026